M Bertrand

5.7k total citations
64 papers, 2.9k citations indexed

About

M Bertrand is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M Bertrand has authored 64 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M Bertrand's work include Cardiac Imaging and Diagnostics (22 papers), Coronary Interventions and Diagnostics (18 papers) and Lipoproteins and Cardiovascular Health (7 papers). M Bertrand is often cited by papers focused on Cardiac Imaging and Diagnostics (22 papers), Coronary Interventions and Diagnostics (18 papers) and Lipoproteins and Cardiovascular Health (7 papers). M Bertrand collaborates with scholars based in France, Netherlands and Italy. M Bertrand's co-authors include J. M. Lablanche, Christophe Bauters, E McFadden, J M Lablanche, Pierre Y. Tilmant, Jean L. Fourrier, Eric Boersma, K. Fox, F. Thieuleux and J C Fruchart and has published in prestigious journals such as Circulation, European Heart Journal and Cardiovascular Research.

In The Last Decade

M Bertrand

61 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Bertrand France 24 1.8k 1.2k 804 530 283 64 2.9k
Lawrence Title Canada 25 1.6k 0.9× 1.5k 1.3× 626 0.8× 446 0.8× 357 1.3× 45 3.2k
David Hasdai United States 26 1.7k 1.0× 861 0.7× 679 0.8× 232 0.4× 579 2.0× 78 2.7k
Seiji Hokimoto Japan 30 1.8k 1.0× 988 0.8× 701 0.9× 407 0.8× 222 0.8× 166 3.1k
Raymond D. Magorien United States 28 2.5k 1.4× 1.3k 1.0× 595 0.7× 237 0.4× 187 0.7× 65 3.7k
Witold Rużyłło Poland 20 1.3k 0.7× 1.3k 1.1× 533 0.7× 506 1.0× 116 0.4× 104 2.5k
Toshiaki Ebina Japan 32 1.8k 1.0× 1.0k 0.8× 761 0.9× 330 0.6× 286 1.0× 197 3.4k
Shuaib Abdullah United States 30 2.2k 1.2× 1.6k 1.3× 1.2k 1.4× 321 0.6× 255 0.9× 76 3.5k
James M. McLenachan United Kingdom 16 2.1k 1.2× 562 0.5× 489 0.6× 282 0.5× 593 2.1× 48 2.8k
Dong Joo Oh South Korea 30 2.1k 1.2× 1.1k 0.9× 752 0.9× 239 0.5× 195 0.7× 219 3.1k
Ad J. van Boven Netherlands 28 2.1k 1.2× 2.3k 1.8× 770 1.0× 581 1.1× 105 0.4× 69 3.7k

Countries citing papers authored by M Bertrand

Since Specialization
Citations

This map shows the geographic impact of M Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bertrand more than expected).

Fields of papers citing papers by M Bertrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bertrand. The network helps show where M Bertrand may publish in the future.

Co-authorship network of co-authors of M Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of M Bertrand. A scholar is included among the top collaborators of M Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Bertrand. M Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brugts, Jasper J., Hisatomi Arima, W. Remme, et al.. (2014). The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. International Journal of Cardiology. 176(3). 718–723. 46 indexed citations
2.
Vark, Laura C. van, M Bertrand, K. Martijn Akkerhuis, et al.. (2012). Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients. European Heart Journal. 33(16). 2088–2097. 283 indexed citations
3.
4.
Bertrand, M, et al.. (2007). Characterizing Novice Behavior Associated With Learning Ultrasound-Guided Peripheral Regional Anesthesia. Regional Anesthesia & Pain Medicine. 32(2). 107–115. 201 indexed citations
5.
Bots, Michiel L., Willem J. Remme, Thomas F. Lüscher, et al.. (2007). ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial. Cardiovascular Drugs and Therapy. 21(4). 269–279. 40 indexed citations
6.
Ceconi, Claudio, K. Fox, W. Remme, et al.. (2006). ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovascular Research. 73(1). 237–246. 135 indexed citations
7.
8.
Castro, G.R., et al.. (1997). Subclasses of LpA‐I in coronary artery disease: distribution and cholesterol efflux ability. European Journal of Clinical Investigation. 27(4). 299–307. 11 indexed citations
9.
Lablanche, J M, E McFadden, J.L. Bonnet, et al.. (1996). Combined antiplatelet therapy with ticlopidine and aspirin: A simplified approach to intracoronary stent management. European Heart Journal. 17(9). 1373–1380. 53 indexed citations
10.
Bauters, Christophe, J. M. Lablanche, E McFadden, Fabrice Leroy, & M Bertrand. (1993). Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris. European Heart Journal. 14(2). 235–239. 15 indexed citations
11.
Lablanche, J. M., Christophe Bauters, E McFadden, P Quandalle, & M Bertrand. (1993). Potassium channel activators in vasospastic angina. European Heart Journal. 14(suppl B). 22–24. 14 indexed citations
12.
Hamon, M., Christophe Bauters, Claude Delcayre, et al.. (1993). Heparin does not inhibit oncogene induction in rabbit aorta following balloon denudation. Cardiovascular Research. 27(7). 1209–1213. 12 indexed citations
13.
Lallemant, Robert, Christophe Bauters, Fabrice Leroy, J. M. Lablanche, & M Bertrand. (1992). [Coronary angioplasty of multivessel coronary diseases. Apropos of 1664 procedures. Immediate results and results following 6 months].. PubMed. 85(6). 815–22. 1 indexed citations
14.
Bauters, Christophe, Pascal de Groote, Claude Delcayre, et al.. (1992). Proto-oncogene expression in rabbit aorta after wall injury First marker of the cellular process leading to restenosis after angioplasty?. European Heart Journal. 13(4). 556–559. 49 indexed citations
15.
Bertrand, M, et al.. (1991). [Guidelines for the training of practitioners in coronary angiography and angioplasty, the organization and equipment of centres of coronary angiography and transluminal angioplasty].. PubMed. 84(12). 1783–7. 2 indexed citations
16.
Puchois, Pascal, A. Kandoussi, P. Fievet, et al.. (1987). Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis. 68(1-2). 35–40. 284 indexed citations
17.
Bertrand, M, et al.. (1987). Percutaneous transluminal coronary angioplasty in patients with spasm superimposed on atherosclerotic narrowing.. Heart. 58(5). 469–472. 14 indexed citations
18.
Bertrand, M, et al.. (1983). The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. European Heart Journal. 4(8). 532–535. 36 indexed citations
19.
Bertrand, M, et al.. (1980). Surgical treatment of variant angina: use of plexectomy with aortocoronary bypass.. Circulation. 61(5). 877–882. 49 indexed citations
20.
Warembourg, H, G Biserte, M Bertrand, & G Sézille. (1964). [COMPARATIVE STUDY OF THE LIPID COMPOSITION OF THE PLASMA IN THE HEALTHY SUBJECT AND IN SIMPLE AND COMPLICATED DIABETES].. PubMed. 72. 2439–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence Title Breakdown of academic impact, for papers by David Hasdai Breakdown of academic impact, for papers by Seiji Hokimoto Breakdown of academic impact, for papers by Raymond D. Magorien Breakdown of academic impact, for papers by Witold Rużyłło Breakdown of academic impact, for papers by Toshiaki Ebina Breakdown of academic impact, for papers by Shuaib Abdullah Breakdown of academic impact, for papers by James M. McLenachan Breakdown of academic impact, for papers by Dong Joo Oh Breakdown of academic impact, for papers by Ad J. van Boven
Rankless by CCL
2026